...
首页> 外文期刊>Egyptian Journal of Medical Human Genetics >Correlation between alanine aminotransferase level, HCV-RNA titer and fibrosis stage in chronic HCV genotype 4 infection
【24h】

Correlation between alanine aminotransferase level, HCV-RNA titer and fibrosis stage in chronic HCV genotype 4 infection

机译:慢性HCV基因型4感染的丙氨酸转氨酶水平,HCV-RNA滴度与纤维化阶段的相关性

获取原文

摘要

The relationship of serum alanine aminotransferase (ALT) level and viral replication to liver damage in chronic hepatitis C virus (HCV) patients remains unclear. The aim of the present study was to determine whether the stage of fibrosis correlates with HCV-RNA titer and/or serum ALT level in patients with chronic hepatitis C (genotype 4) infection. Clinical and biochemical characteristics were collected from 138 patients with chronic HCV genotype 4 infection. Quantitative HCV-RNA level measurement, HCV genotyping, and abdominal ultrasonography were investigated in all patients. Liver biopsy was done for 80 patients and the remaining 58 patients were examined using Fibroscan. Highly significant higher percentage of cases with high level of HCV viremia was found among patients with fibrosis stage 3 as compared to other stages of fibrosis. In contrast, grades of activity were independent of serum HCV-RNA titer. Patients with stages 1 and 4 hepatic fibrosis had significantly higher levels of ALT than patients with other stages of fibrosis. In contrast, an insignificant correlation was found between ALT level and grade of necroinflammation. In conclusion neither ALT level nor HCV viremia can reflect the histological liver change accurately. As a result, liver biopsy or other noninvasive procedures that measure liver stiffness (i.e., Fibroscan) remain essential for accurate staging of liver fibrosis in patients with genotype 4 chronic HCV infection.
机译:慢性丙型肝炎病毒(HCV)患者血清丙氨酸氨基转移酶(ALT)水平和病毒复制与肝损伤之间的关系尚不清楚。本研究的目的是确定慢性丙型肝炎(基因型4)感染患者的纤维化阶段是否与HCV-RNA滴度和/或血清ALT水平相关。从138例慢性HCV基因型4感染患者中收集临床和生化特征。所有患者均进行了定量HCV-RNA水平测量,HCV基因分型和腹部超声检查。对80例患者进行了肝活检,其余58例使用Fibroscan检查。与其他纤维化阶段相比,在纤维化阶段3的患者中,HCV病毒血症水平高的病例比例高得多。相反,活性等级与血清HCV-RNA滴度无关。患有肝纤维化的1期和4期患者的ALT水平明显高于患有其他肝纤维化阶段的患者。相反,在ALT水平与坏死性炎症程度之间没有显着相关性。总之,ALT水平和HCV病毒血症均不能准确反映肝组织学变化。结果,对于具有基因型4型慢性HCV感染的患者,肝活检或其他测量肝硬度的非侵入性程序(即Fibroscan)仍然是准确分期肝纤维化的关键。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号